<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Health — Live Feed</title><link>https://www.live-feeds.com/feed/health</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/health/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>US peptide boom exposes risks of unregulated 'miracle' drugs; cancer patient calls for UK treatment reforms</title><link>https://www.live-feeds.com/feed/health</link><guid isPermaLink="false">https://www.live-feeds.com/feed/health#u1243</guid><pubDate>Tue, 16 Jun 2026 13:32:00 +0000</pubDate><description>The US is seeing a surge in unregulated peptide use for weight loss and cosmetic effects, despite warnings of unknown dangers. A UK swimmer with rare brain cancer highlights the lack of progress in developing new treatments. Meanwhile, ongoing reviews of obesity drugs, women’s pain care, and welfare cuts persist.What's confirmed:Thousands of Americans are injecting unregulated peptides—labeled &amp;#039;not for human consumption&amp;#039;—for weight loss, muscle growth, and anti-aging, despite potential unknown side effects.Online availability and influencer promotion have driven the rise of peptides </description></item>
<item><title>Vaccine fraud fallout persists as climate risks expose children globally</title><link>https://www.live-feeds.com/feed/health</link><guid isPermaLink="false">https://www.live-feeds.com/feed/health#u849</guid><pubDate>Tue, 16 Jun 2026 06:37:58 +0000</pubDate><description>A retracted vaccine study remains a flashpoint, while Melbourne’s Cohealth system faces ongoing scrutiny. The UK pushes for a new obesity drug, and women’s pain treatment options stay under review. Meanwhile, nearly all children worldwide face climate-related hazards, and UK welfare cuts spark safety debates.What's confirmed:Almost every child globally—including those in wealthy nations—faces at least one climate-related hazard, with half exposed to three or more.UK defence spending increases risk making millions less safe by cutting welfare, according to Guardian columnist Frances Ryan.No new</description></item>
<item><title>RFK Jr. vaccine study dispute; Australia’s Cohealth crisis; UK obesity drug push</title><link>https://www.live-feeds.com/feed/health</link><guid isPermaLink="false">https://www.live-feeds.com/feed/health#u554</guid><pubDate>Tue, 16 Jun 2026 01:51:58 +0000</pubDate><description>A high-profile clash over a retracted vaccine study dominates headlines, while systemic failures in Melbourne’s Cohealth system persist. The UK advances plans for a Wegovy pill, and women’s pain relief options remain under review. No new global health emergencies are confirmed.What's confirmed:RFK Jr. has faced backlash for a letter demanding answers from a scientific journal that retracted a vaccine study over flaws, with health advocates calling the move bullying.A report on Melbourne’s Cohealth revealed systemic problems were ignored for a decade, despite clinicians raising concerns and off</description></item>
<item><title>Hantavirus cruise scare ends; Wegovy pill nears UK; cramps pain relief concerns persist</title><link>https://www.live-feeds.com/feed/health</link><guid isPermaLink="false">https://www.live-feeds.com/feed/health#u172</guid><pubDate>Mon, 15 Jun 2026 19:57:36 +0000</pubDate><description>A cruise ship hantavirus outbreak has been contained without wider spread, while the UK prepares for a pill version of Wegovy. Women’s pain relief choices for cramps remain under scrutiny, and resident doctors’ strike threats have eased. No new major health emergencies are confirmed globally.What's confirmed:The hantavirus outbreak on a cruise ship has ended without further cases, marking a successful containment effort.The UK is set to approve Wegovy as an oral pill, expanding treatment options for obesity.Women may be opting for weaker pain relief for period cramps due to cost or availabilit</description></item>
<item><title>Period pain relief, hypermobility delays and NHS strikes: UK health update</title><link>https://www.live-feeds.com/feed/health</link><guid isPermaLink="false">https://www.live-feeds.com/feed/health#u17</guid><pubDate>Mon, 15 Jun 2026 13:14:31 +0000</pubDate><description>Women may be buying weaker pain relief for period cramps, hypermobility diagnoses face long waits, and resident doctors have called off a strike. Meanwhile, a new vaccine rollout targets meningitis B, and Wegovy will soon be available as a pill in the UK.What's confirmed:Supermarket data suggests many women are purchasing less effective pain medication for period cramps, potentially due to misinformation or product availability.People with hypermobile Ehlers-Danlos syndrome in the UK wait an average of up to 21 years for a diagnosis, partly due to low awareness among healthcare professionals.A</description></item>
</channel></rss>